[Gln11]-beta-Amyloid (1-16) introduces a polar amide side chain affecting early folding events in the N-terminal region. The peptide segment supports studies of metal-binding motifs and initial conformational transitions. Its modified sequence helps evaluate residue-specific impacts on structure. Researchers use it in aggregation initiation, biophysics, and peptide-metal analysis.
CAT No: A13121
3. Store-operated Ca2+ entry sustains the fertilization Ca2+ signal in pig eggs
5. High fat diet and GLP-1 drugs induce pancreatic injury in mice
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More